Kelly, a former cancer research scientist, is now focused on biopharmaceutical and pharmaceutical applications. Kelly has enjoyed spending most of her career, thus far, utilizing the power of mass spectrometry to help improve our understanding of human disease. She has a strong background in biomedical sciences, including a Masters in Biomedical Science, a PhD in Cancer Proteomics and a post-doctoral position in Systems Oncology. Kelly maintains a keen interest in biotherapeutic research and drug development and is motivated by the ability to facilitate customer success through innovative technology and powerful workflow solutions.
Company:Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.